Amylyx Pharmaceuticals Return on Invested Capital from 2010 to 2024
| AMLX Etf | USD 1.95 0.03 1.52% |
Check Amylyx Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amylyx main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Amylyx financial statements analysis is a perfect complement when working with Amylyx Pharmaceuticals Valuation or Volatility modules.
Amylyx |
About Amylyx Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Amylyx Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Amylyx Pharmaceuticals investors use historical funamental indicators, such as Amylyx Pharmaceuticals's Return on Invested Capital, to determine how well the company is positioned to perform in the future. Although Amylyx Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Amylyx Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Amylyx Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Amylyx Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Amylyx Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis and other neurodegenerative diseases. Amylyx Pharmaceuticals is listed under Biotechnology in the United States and is traded on NASDAQ Exchange exchange.
Pair Trading with Amylyx Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amylyx Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amylyx Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Amylyx Etf
| 0.8 | KA | Kineta Inc Financial Report 9th of May 2024 | PairCorr |
| 0.75 | ME | 23Andme Holding | PairCorr |
Moving against Amylyx Etf
| 0.87 | YS | YS Biopharma | PairCorr |
| 0.72 | DSGN | Design Therapeutics Downward Rally | PairCorr |
| 0.65 | DOMH | Dominari Holdings | PairCorr |
| 0.62 | A | Agilent Technologies Earnings Call This Week | PairCorr |
| 0.49 | DNTH | Dianthus Therapeutics Symbol Change | PairCorr |
The ability to find closely correlated positions to Amylyx Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amylyx Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amylyx Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amylyx Pharmaceuticals to buy it.
The correlation of Amylyx Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amylyx Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amylyx Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amylyx Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Amylyx Pharmaceuticals Correlation against competitors. For more information on how to buy Amylyx Etf please use our How to Invest in Amylyx Pharmaceuticals guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
The market value of Amylyx Pharmaceuticals is measured differently than its book value, which is the value of Amylyx that is recorded on the company's balance sheet. Investors also form their own opinion of Amylyx Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Amylyx Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amylyx Pharmaceuticals' market value can be influenced by many factors that don't directly affect Amylyx Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amylyx Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amylyx Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amylyx Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.